EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 62019TA0261

Case T-261/19: Judgment of the General Court of 20 January 2021 — Stada Arzneimittel v EUIPO — Optima Naturals (OptiMar) (EU trade mark — Opposition proceedings — Application for the EU figurative mark OptiMar — Earlier national word mark Mar — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

OJ C 72, 1.3.2021, p. 21–21 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

1.3.2021   

EN

Official Journal of the European Union

C 72/21


Judgment of the General Court of 20 January 2021 — Stada Arzneimittel v EUIPO — Optima Naturals (OptiMar)

(Case T-261/19) (1)

(EU trade mark - Opposition proceedings - Application for the EU figurative mark OptiMar - Earlier national word mark Mar - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2021/C 72/30)

Language of the case: English

Parties

Applicant: Stada Arzneimittel AG (Bad Vilbel, Germany) (represented by: J.-C. Plate and R. Kaase, lawyers)

Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral and V. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Optima Naturals Srl (Gallarate, Italy) (represented by: S. Brustia and E. Montelione, lawyers)

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 31 January 2019 (Case R 1348/2018-1), relating to opposition proceedings between Stada Arzneimittel and Optima Naturals.

Operative part of the judgment

The Court:

1.

Dismisses the action;

2.

Orders Stada Arzneimittel AG to pay the costs.


(1)  OJ C 206, 17.6.2019.


Top